This study asks whether arterial blood ionized calcium concentration (Ca++) can regulate the serum level of 1,25-dihydroxyvitamin D3 I1,25(OH)2D31 independently of serum phosphorus and parathyroid hormone (PTH). We infused either PTH (bovine 1-34, 10 U/kg body wt/h) or saline into awake and unrestrained rats for 24 h, through a chronic indwelling catheter. PTH raised total serum calcium and arterial blood ionized calcium, yet serum 1,25(OH)2D3 fell from 35±6 (mean±SEM, n = 10) with saline to 12±3 pg/ml (n = 11, P < 0.005 vs. saline). To determine if the decrease in serum 1,25(OH)2D3 was due to the elevated Ca", we infused PTH into other rats for 24 h, along with varying amounts of EGTA. Infusion of PTH + 0.67 Mm/min EGTA reduced Ca++, and 1,25(OH)2D3 rose to 90±33 (P < 0.02 vs. PTH alone). PTH + 1.00 um/min EGTA lowered Ca++ more, and 1,25(OH)2D3 increased to 148±29 (P < 0.01 vs. saline or PTH alone). PTH + 1.33 ,um/min EGTA lowered Ca++ below values seen with saline or PTH alone, and 1,25(OH)2D3 rose to 267±46 (P < 0.003 vs. all other groups). Thus, during PTH infusion lowering Ca++ with EGTA raised 1,25(OH)2D3 progressively. There were no differences in serum phosphorus concentration or in arterial blood pH in any group infused with PTH. The log of serum 1,25(OH)2D3 was correlated inversely with Ca++ in all four groups infused with PTH (r = -0.737, n = 31, P < 0.001), and also when the saline group was included (r = -0.677, n = 41, P < 0.001). The results of this study indicate that serum 1,25(0H)2D3 may be regulated by Ca++ independent of PTH and serum phosphorus levels in the rat. Since
Introduction
It is difficult to tell ifblood ionized calcium concentration (Ca++)' directly regulates the production and serum level of 1,25-dihy-droxyvitamin D3 [1, 25(OH) 2D3]. Because increased Ca" downregulates secretion of parathyroid hormone (PTH), and PTH can stimulate 1,25(OH)2D3 production directly (1) (2) (3) (4) and by lowering blood phosphorus concentration (5, 6) , any change in Ca"+ that alters PTH can affect 1,25(OH)2D3 via PTH. Consequently, direct effects of Ca"+ itself upon serum 1,25(OH)2D3 are difficult to isolate. Parathyroidectomy, an obvious way to disentangle the effects of Ca"+ and PTH, produces hyperphosphatemia and hypocalcemia that complicate the interpretation of experimental results. For example, low calcium diet raises serum 1,25(OH)2D3 (5, (7) (8) (9) (10) (11) (12) and PTH (5, 7, (10) (11) (12) in rats; in some experiments 1,25(OH)2D3 increases despite parathyroidectomy (1 1, 13, 14) but in others it does not (5, 15) . At best, the response of 1,25(OH)2D3 to low calcium diet is much below normal after parathyroidectomy (1 1) . Whether the variable and submaximal response of serum 1,25(OH)2D3 to low calcium diet is due to hyperphosphatemia, lack of PTH, or the fact that Ca"+ truly can regulate serum 1,25(OH)2D3 only weakly, is not clear. Chronic metabolic acidosis raised blood Ca"+ and lowered 1,25(OH)2D3 in rats eating a low calcium diet even though their PTH levels, judged by radioimmunoassay, seemed the same as in nonacidotic rats eating the same diet (12) . However, small changes in PTH that the assay cannot register, may affect 1,25(OH)2D3 production, so the experiment is not a critical test of the hypothesis that Ca"+ directly regulates 1,25(OH)2D3.
It is worthwhile to look for a direct effect of Ca"+ on 1,25(OH)2D3 in vivo, because medium Ca"+ can regulate 1,25(OH)2D3 production in vitro. Conversion of 25(OH)D3 to 1,25(OH)2D3 by kidney homogenates (16, 17) , isolated tubules (18) , and kidney cells (19) is inhibited by increased medium calcium. Incidentally, mitochondrial conversion is promoted by increased Ca"+ (20) , suggesting a difference between calcium effects on cells and mitochondria.
Our strategy in the present study was to infuse large amounts of PTH for 24 h, to minimize the influence ofendogenous PTH secretion on 1,25(OH)2D3 production, to stabilize serum phosphorus by providing an ample dietary phosphorus supply, and to lower arterial blood Ca++ by infusing EGTA. The question was whether Ca++ can regulate serum 1,25(OH)2D3 levels despite a constant, high PTH infusion and stable serum phosphorus levels; our result was that it can.
Methods

Animals
We placed chronic arterial and venous catheters in 250-275 g adult male Sherman rats (Camm Research Lab Animals, Wayne, NJ) under light hexobarbitol anesthesia ( 12, 21) . After surgery, we placed each rat in its own metabolic cage and connected the catheters, encased in a stainless steel spring, to a swivel device ( (25) .
Infusions and collections. We adjusted all solutions to pH 7.40 with concentrated HCl or NaOH before infusion. At the initiation of each 24-h infusion, 0.4 ml ofthe infusate was given over the first 3 min. From the fourth day after surgery we measured food and fluid intake daily in all rats and eliminated those rats that ate less than 13 g of food or drank less than 15 ml of fluid on any day. We measured calcium, creatinine, phosphorus, and cyclic AMP in the urine that was collected (in 0.25 ml of 12 N HCl) during the 24-h infusion. At the end of the infusion we withdrew blood from the arterial catheter without anesthesia and then sacrificed the rats. Some whole blood was used for acid-base and Ca++ measurements. From the rest ofthe blood we separated serum from cells within 30 min, and froze a portion of it at -25°C for 1,25(OH)2D3 measurements. The rest of the serum was used for the remainder of the measurements. Each rat was infused only once.
Biological activity ofPTH
To verify the biological activity of the infused PTH we tested its ability to enhance calcium resorption from neonatal mouse calvariae. 4-6-d old Swiss Cox mice were killed and their calvariae were removed by dissection (26, 27). Exactly 2.8 ml of culture medium (Dulbecco's modified Eagles medium with 4.5 g/liter glucose, heat-inactivated [1 h at 56°C] horse serum [15%] , and sodium heparin [10 U/ml]) at pH between 7.35 and 7.45 (adjusted with concentrated HCI or NaOH) was preincubated at 37°C, Pco2 40 mmHg, for 3 h in 35-mm Petri dishes. 1 ml was then removed to determine preincubation medium pH, Pco2, and calcium concentration, and two calvariae were placed in the dish on a stainless steel wire grid. Bones were cultured for 24 h, at 37°C, with or without 10-8 M PTH and then a second sample of culture medium was obtained and similarly analyzed.
2. To the best of our knowledge no studies exist that relate PTH infusion to production of 1,25(OH)2D3 in vivo, in rat proximal tubule cells, from which we could derive that infusion rate which provides maximal hormonal stimulation to 1,25(OH)2D3 production.
Calvariae incubated with PTH raised medium calcium by 1.32±0.08 mg/dl vs. 0.25±0.07 in control bones (P < 0.001). Net calcium flux, calculated as the final calcium concentration minus the initial calcium concentration times the volume ofculture medium divided by two bones, was higher with PTH incubation (297±18 nmol/bone/24 h vs. 57±16, PTH vs. control, P < 0.001, Table I ). The increases in medium calcium and calcium flux with PTH are similar to what we (26, 27) and others (28) have found previously, and indicate that the hormone was biologically active. There was no difference in initial medium calcium, pH, Pco2, or bicarbonate between bone cultures with or without PTH (Table I) .
1,25(OH)2D3 measurements
We thawed 1-2 ml of serum from each rat at room temperature, and added 1,500 cpm of [3H] 1,25(OH)2D3 (specific activity, 91 Ci/mmol; Amersham Corp., Arlington Heights, IL) to monitor procedural losses. Lipid-soluble vitamin D metabolites were extracted from serum with methylene chloride/methanol (1:1) and washed twice with phosphate buffer (pH = 10.4). 1,25(OH)2D3 was separated from other metabolites and contaminants by Sephadex LH 20 gravity flow chromatography, and then by high performance liquid chromatography (HPLC) using previously described solvent systems (10, 12, 21, 29, 30) . The HPLC effluent containing 1,25(OH)2D3 was assayed in triplicate in a competitive binding radioreceptor assay that uses the 100,000 g supernatant of homogenized vitamin D-deficient chick intestinal epithelium as the source of the 1,25(OH)2D3 receptor (31) . Sensitivity of the assay ranged from 2 to 7 pg/assay tube. Interassay coefficient of variation between the five assays performed was 19.6%. Overall sample recovery was 55±5%.
Other laboratory measurements
We measured arterial blood ionized calcium using a micro-electrode (Orion Biomedical Space Stat 20; Orion Research Inc., Cambridge, MA [12] ), and total calcium in serum and urine by atomic absorption spectrophotometry (Instrumentation Laboratory, Lexington, MA) using aqueous standards (12, 29, 30) . We measured creatinine in urine and phosphorus in serum and urine using an Autoanalyzer (Model AA1; Technicon Instruments Corp., Tarrytown, NY), serum creatinine by the Heinegard and Tiderstrom modification ofthe Jaffe reaction, and urinary cyclic AMP using radioimmunoassay (New England Nuclear, Boston, MA) (12, 29, 30) . We measured arterial blood pH and Pco2 using a pHblood gas analyzer (Radiometer BMS Mk3, Copenhagen, Denmark). We calculated plasma bicarbonate concentration from the pH and Pco2 using the Henderson-Hasselbalch equation with a solubility coefficient of 0.0306 and pK of 6.099 (at pH 7.40) that was corrected for pH (12, 21, 26, 27) .
Statistical methods
We assessed differences between groups using t tests that did not assume equal variances in the groups being compared. Regressions were calculated by least squares. 
Results
Ionized calcium, phosphorus, and J,25(OH)2D3. Infusion of PTH increased arterial Ca++ and lowered serum 1,25(OH)2D3 (Fig.  1 , X symbol) compared with saline alone (Fig. 1, closed circle) . Serum 1,25(OH)2D3 fell in response to PTH infusion, even though the PTH raised both total calcium level and Ca", and lowered serum phosphorus level (Table I; and Fig. 1 ).
To test the idea that increased Ca++ itself had suppressed serum 1,25(OH)2D3 despite PTH excess, we infused the same amount of PTH with three different concentrations of EGTA, to lower Ca". As Ca++ was lowered progressively, serum 1,25(OH)2D3 rose (Fig. 1, open Table II) . Log serum 1,25(OH)2D3 was correlated inversely with Ca++ in the four groups infused with PTH (r = -0.737, n = 31, P < 0.001; log 1,25(OH)2D3 =-4.24 X Ca" + 6.95) and also when the saline group is included (r = -0.677, n = 41, P < 0.001; log 1,25(OH)2D3 = -3.93 X Ca' + 6.52).
Serum and blood gas measurements. Infusion of PTH alone increased total serum calcium and decreased serum phosphorus levels (Table II) . Infusions of EGTA with PTH did not alter serum calcium or phosphorus levels compared with saline or PTH alone (Table II) . PTH with 1.00 or 1.33 EGTA increased the serum magnesium level compared with saline. All three groups of rats infused with EGTA + PTH were alkalemic and hypocapnic compared with rats infused with saline (Table III) .
Urine measurements. PTH infusion with or without EGTA increased urine calcium excretion (Table IV) . All three infusions of EGTA with PTH increased urine phosphorus and depressed urine magnesium excretions (Table IV) . The final weight of rats in the five groups did not differ (Table IV) There exist no in vivo studies in rats that are exactly comparable to ours. Low calcium diet raises serum 1,25(OH)2D3, and could reduce Ca++ transiently; but low calcium diet also raises serum PTH level (5, 7, (10) (11) (12) , so direct effects of Ca++ itself cannot be discerned. Thyroparathyroidectomized (TPTX) rats also may respond to low calcium diet with an increase in either serum 1 ,25(OH)2D3 (11, 13) or tissue 1 ,25(OH)2D3 localization (14) . A response of serum 1,25(OH)2D3 to low calcium diet despite TPTX supports our present result. Serum phosphorus level increases after TPTX, and rises during low calcium diet (1 1, 13) , so the response of 1,25(OH)2D3 to low calcium diet occurs despite hyperphosphatemia. Unfortunately, the ef- Ca, calcium; P, phosphorus; Mg, magnesium. Saline, rats infused with 75 mM NaCI at 0.4 ml/h for 24 h; PTH, rats infused with 10 U/kg body wt/h of synthetic bovine 1-34 parathyroid hormone for 24 h; PTH + 0.67 EGTA, rats infused with PTH and 0.67 Aim/min of EGTA for 24 h; PTH + 1.0 EGTA, rats infused with PTH and 1.0 jm/min of EGTA for 24 h; EGTA + 1.33 EGTA, rats infused with PTH and 1.33 jm/min of EGTA for 24 h; *, different than saline, P < 0.05; $, different than PTH, P < 0.05; §, different than PTH + 0.67 EGTA, P < 0.05; 11, different than PTH + 1.0 EGTA, P < 0.05. (18); very low medium calcium levels, however, reduce 1,25(OH)2D3 production (18) . Chick mitochondria behave oppositely: raising medium calcium increases 1,25(OH)2D3 production, but over a range of from 106 to 10'-M, far below the regulatory range used for intact cells and only when pH is between 6.5 and 7.0 (20) . These differences underscore the difficulties of comparing mitochondrial and cellular studies.
Superficially, at least, studies in humans appear to contradict our present findings: PTH increases serum 1,25(OH)2D3 in normal people and in patients with hypoparathyroidism despite a rise in serum calcium (1, 4, 34, 35 Overall, in the intact rat provided with a constant excess of PTH, blood ionized calcium level is a direct regulator of serum 1 ,25(OH)2D3 and, perhaps, renal 1 ,25(OH)2D3 production. Whether Ca"+ has the same effects in humans, how ionized calcium actually affects serum 1,25(OH)2D3, and whether Ca`+ has a strong regulatory effect when PTH is normal, rather than high, remain unanswered questions. Since transepithelial active transport of calcium by the intestine is regulated by 1,25(0Hh)D3 (39, 40) , an increase in the hormone augments calcium absorption and can thereby elevate the serum calcium level (41) . Therefore, by directly regulating serum 1,25(OH)2D3, calcium appears to control its own absorption.
